A B S T R A C TA single dose of Myleran suppressed CFU in polycythemic mice to around 1 % of normal for a period of 2 weeks and permitted the study of effects of erythropoietin on unipotential, erythroid stem cells (erythropoietin-responsive cells, ERC) in the absence of cell inflow from the CFU compartment. Without erythropoietin no ERC were detectable for 12 days after Myleran. Injections of erythropoietin had no effect on CFU but restored ERC populations in proportion to the dose of erythropoietin. Hydroxyurea given after erythropoietin markedly inhibited ERC repopulation and the latter is attributed to a stimulation of ERC proliferation by erythropoietin. Evidence in support of an age structure in the ERC population is presented. Daily erythropoietin injection resulted in stable ERC populations, indicating that ERC loss through differentiation and ERC self-replication were in balance.
I N T R O D U C T I O NErythropoietin (Ep) regulates erythropoiesis by governing the rate of differentiation of erythropoietin-responsive cells (ERC) into proerythroblasts (PE), the earliest erythroblasts that can be recognized morphologically. Evidence is mounting to indicate that ERC are not identical with the pluripotential transplantable stem cells (CFU). It now appears likely that the CFU first undergo a partial differentiation into unipotential erythroid stem cells or ERC and these are then induced by erythropoietin to differentiate into PE (Lajtha et al., 1969). During accelerated erythropoiesis, a greater number of ERC is forced into differentiation, and if the ERC population is to be sustained, the greater cell outflow must be balanced either by an increased inflow from the CFU compartment or by increased self-replication of ERC. The exact mechanism and the regulation of this important step in erythropoiesis remain to be elucidated. We have presented evidence of a marked proliferative capability of ERC and have shown that erythropoietin stimulates this process (Reissmann & Samorapoompichit,